JP2005040137A5 - - Google Patents

Download PDF

Info

Publication number
JP2005040137A5
JP2005040137A5 JP2004218009A JP2004218009A JP2005040137A5 JP 2005040137 A5 JP2005040137 A5 JP 2005040137A5 JP 2004218009 A JP2004218009 A JP 2004218009A JP 2004218009 A JP2004218009 A JP 2004218009A JP 2005040137 A5 JP2005040137 A5 JP 2005040137A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004218009A
Other languages
Japanese (ja)
Other versions
JP2005040137A (ja
Filing date
Publication date
Priority claimed from US10/626,905 external-priority patent/US20040121463A1/en
Application filed filed Critical
Publication of JP2005040137A publication Critical patent/JP2005040137A/ja
Publication of JP2005040137A5 publication Critical patent/JP2005040137A5/ja
Withdrawn legal-status Critical Current

Links

JP2004218009A 2003-07-25 2004-07-26 Jnkを標的化することによりプログラム細胞死またはアポトーシスをブロックする新規な因子の同定 Withdrawn JP2005040137A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/626,905 US20040121463A1 (en) 2001-10-02 2003-07-25 Methods and compositions for modulating apoptosis
US52623103P 2003-12-02 2003-12-02

Publications (2)

Publication Number Publication Date
JP2005040137A JP2005040137A (ja) 2005-02-17
JP2005040137A5 true JP2005040137A5 (enExample) 2005-08-11

Family

ID=33567995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004218009A Withdrawn JP2005040137A (ja) 2003-07-25 2004-07-26 Jnkを標的化することによりプログラム細胞死またはアポトーシスをブロックする新規な因子の同定

Country Status (4)

Country Link
US (1) US7326418B2 (enExample)
EP (1) EP1506784A1 (enExample)
JP (1) JP2005040137A (enExample)
AU (1) AU2004203373A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1453467A4 (en) * 2001-10-02 2008-01-09 Univ Chicago METHODS AND COMPOSITIONS FOR MODULATING APOPTOSIS
US20040121463A1 (en) * 2001-10-02 2004-06-24 Guido Franzoso Methods and compositions for modulating apoptosis
US7354898B2 (en) * 2001-10-02 2008-04-08 University Of Chicago Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
CZ297528B6 (cs) * 2005-06-10 2007-01-03 Výzkumný ústav živočišné výroby Použití inhibitoru MAP kinázy JNK pro přípravu kultivačního média na prodloužení životnosti savčích oocytů in vitro
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
US9376709B2 (en) 2010-07-26 2016-06-28 Biomatrica, Inc. Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
EP2508607A1 (en) 2011-04-07 2012-10-10 Helmholtz-Zentrum für Infektionsforschung GmbH Medicament for liver regeneration and for treatment of liver failure
WO2014081728A1 (en) 2012-11-20 2014-05-30 The U.S.A, As Represented By The Secretary, Department Of Health And Human Services Inhibitors of the t cell-specific alternative p38 activation pathway and methods of use
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
CN105491883B (zh) 2013-06-13 2018-11-02 生物马特里卡公司 细胞稳定化
US10064404B2 (en) 2014-06-10 2018-09-04 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
KR102589056B1 (ko) 2015-12-08 2023-10-12 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
CA3086765A1 (en) 2017-12-28 2019-07-04 Tract Pharmaceuticals, Inc. Stem cell culture systems for columnar epithelial stem cells, and uses related thereto

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5866332A (en) 1994-02-02 1999-02-02 Incyte Pharmaceuticals, Inc. Human myeloid terminal differentiation response gene
US6136596A (en) * 1995-05-19 2000-10-24 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US6492112B1 (en) * 1997-12-31 2002-12-10 Chiron Corporation Mitogen-activated protein kinase kinase 7 (MKK7)
US6054440A (en) * 1999-06-24 2000-04-25 Isis Pharmaceuticals Inc. Antisense inhibition of Jun N-terminal Kinase Kinase-2 expression
US7354898B2 (en) * 2001-10-02 2008-04-08 University Of Chicago Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
EP1453467A4 (en) * 2001-10-02 2008-01-09 Univ Chicago METHODS AND COMPOSITIONS FOR MODULATING APOPTOSIS

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enExample)
BE2023C542I2 (enExample)
BE2022C549I2 (enExample)
BE2021C001I2 (enExample)
BE2020C513I2 (enExample)
BE2020C517I2 (enExample)
BE2019C540I2 (enExample)
BE2019C523I2 (enExample)
BE2019C548I2 (enExample)
BE2019C506I2 (enExample)
BE2018C045I2 (enExample)
BE2020C525I2 (enExample)
BE2017C063I2 (enExample)
BE2017C027I2 (enExample)
BE2017C023I2 (enExample)
BE2017C002I2 (enExample)
BE2016C014I2 (enExample)
BE2016C020I2 (enExample)
BE2015C041I2 (enExample)
BE2015C015I2 (enExample)
BE2013C071I2 (enExample)
BE2013C021I2 (enExample)
BE2015C066I2 (enExample)
BE2012C025I2 (enExample)
BE2015C065I2 (enExample)